Silexion Therapeutics Corp SEC filings SLXN
Silexion Therapeutics Corp has 279 filings in SEC EDGAR's recent list, going back to May 9, 2024. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 28, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 26, 2026 | Oct 26, 2026 |
| DEFA14A | Additional proxy material | Oct 19, 2026 | — |
| DEF 14A | Proxy statement | Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| 424B3 | Prospectus | Sep 29, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 25, 2026 | Sep 25, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 25, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 25, 2026 | Sep 25, 2026 |
| DEFA14A | Additional proxy material | Sep 16, 2026 | — |
| DEFA14A | Additional proxy material | Sep 9, 2026 | — |
| DEF 14A | Proxy statement | Aug 24, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 21, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 424B4 | Prospectus | Aug 13, 2026 | — |
| EFFECT | Filing | Aug 11, 2026 | — |
| S-1/A | Amended registration statement | Aug 10, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| S-1 | Registration statement | Aug 7, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 21, 2026 | Jul 21, 2026 |
| DEFA14A | Additional proxy material | Jul 13, 2026 | — |
| EFFECT | Filing | Jun 18, 2026 | — |
| 424B3 | Prospectus | Jun 18, 2026 | — |
| DEF 14A | Proxy statement | Jun 16, 2026 | Jun 16, 2026 |
| CORRESP | Letter to the SEC | Jun 16, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2026 | — |
| S-3 | Shelf registration | Jun 12, 2026 | — |
| PRE 14A | Preliminary proxy statement | Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 29, 2026 | May 29, 2026 |
| S-8 | Employee stock plan registration | May 28, 2026 | — |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
| 10-K/A | Amended annual report | May 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 18, 2026 | May 18, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| EFFECT | Filing | May 11, 2026 | — |
| EFFECT | Filing | May 11, 2026 | — |
| POS AM | Filing | May 7, 2026 | — |
| POS AM | Filing | May 7, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 5, 2026 | May 5, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2026 | Apr 28, 2026 |
| DEF 14A | Proxy statement | Apr 9, 2026 | Apr 9, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 23, 2026 | Mar 23, 2026 |
| DRS | Filing | Mar 17, 2026 | — |
| 10-K | Annual report | Mar 17, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Mar 16, 2026 | — |
| DEF 14A | Proxy statement | Feb 23, 2026 | Feb 23, 2026 |
| S-8 | Employee stock plan registration | Feb 19, 2026 | — |
| PRE 14A | Preliminary proxy statement | Feb 13, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| S-3 | Shelf registration | Oct 31, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2025 | Sep 30, 2025 |
| CORRESP | Letter to the SEC | Sep 30, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| S-3 | Shelf registration | Sep 26, 2025 | — |
| 8-K |
Current report
Material agreement
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Other events
|
Sep 25, 2025 | Sep 25, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 12, 2025 | Sep 11, 2025 |
| 424B4 | Prospectus | Sep 12, 2025 | — |
| EFFECT | Filing | Sep 11, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2025 | Sep 11, 2025 |
| CORRESP | Letter to the SEC | Sep 9, 2025 | — |
| CORRESP | Letter to the SEC | Sep 9, 2025 | — |
| S-1 | Registration statement | Sep 5, 2025 | — |
| EFFECT | Filing | Sep 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2025 | Sep 4, 2025 |
| 424B3 | Prospectus | Sep 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| CORRESP | Letter to the SEC | Sep 2, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| S-1 | Registration statement | Aug 26, 2025 | — |
| S-8 | Employee stock plan registration | Aug 20, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 20, 2025 | Aug 20, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Aug 19, 2025 | Aug 19, 2025 |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 424B3 | Prospectus | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| DEFA14A | Additional proxy material | Aug 12, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| D | Filing | Aug 11, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 1, 2025 | Aug 1, 2025 |
| 424B3 | Prospectus | Aug 1, 2025 | — |
| 424B3 | Prospectus | Aug 1, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2025 | Jul 31, 2025 |
| DEF 14A | Proxy statement | Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 21, 2025 | Jul 21, 2025 |
| PRE 14A | Preliminary proxy statement | Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 14, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K/A |
Amended current report
Other events
|
Jul 8, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 8, 2025 | Jul 8, 2025 |
| DEFA14A | Additional proxy material | Jul 7, 2025 | — |
| DEFA14A | Additional proxy material | Jun 23, 2025 | — |
| DEF 14A | Proxy statement | Jun 16, 2025 | Jun 16, 2025 |
| PRE 14A | Preliminary proxy statement | Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| EFFECT | Filing | May 29, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2025 | May 29, 2025 |
| POS AM | Filing | May 28, 2025 | — |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2025 | May 21, 2025 |
| 424B3 | Prospectus | May 13, 2025 | — |
| 424B3 | Prospectus | May 13, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 424B3 | Prospectus | May 6, 2025 | — |
| EFFECT | Filing | May 1, 2025 | — |
| POS AM | Filing | Apr 29, 2025 | — |
| AW | Filing | Apr 29, 2025 | — |
| AW | Filing | Apr 29, 2025 | — |
| 424B3 | Prospectus | Apr 29, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| EFFECT | Filing | Apr 25, 2025 | — |
| POS AM | Filing | Apr 23, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 23, 2025 |
| DRS | Filing | Apr 23, 2025 | — |
| POS AM | Filing | Apr 10, 2025 | — |
| POS AM | Filing | Apr 10, 2025 | — |
| EFFECT | Filing | Apr 1, 2025 | — |
| 424B3 | Prospectus | Apr 1, 2025 | — |
| CORRESP | Letter to the SEC | Apr 1, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| S-1/A | Amended registration statement | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 424B3 | Prospectus | Mar 14, 2025 | — |
| 8-K |
Current report
Material agreement
|
Mar 14, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| UPLOAD | Letter from the SEC | Feb 19, 2025 | — |
| S-1 | Registration statement | Feb 12, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 30, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 17, 2025 | Jan 15, 2025 |
| 424B4 | Prospectus | Jan 17, 2025 | — |
| EFFECT | Filing | Jan 15, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| CORRESP | Letter to the SEC | Jan 14, 2025 | — |
| S-1/A | Amended registration statement | Jan 14, 2025 | — |
| S-1/A | Amended registration statement | Jan 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 424B3 | Prospectus | Dec 10, 2024 | — |
| 424B3 | Prospectus | Dec 10, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Dec 10, 2024 | Dec 10, 2024 |
| 424B3 | Prospectus | Nov 29, 2024 | — |
| 424B3 | Prospectus | Nov 29, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 29, 2024 | Nov 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 27, 2024 | Nov 27, 2024 |
| 424B3 | Prospectus | Nov 22, 2024 | — |
| 424B3 | Prospectus | Nov 22, 2024 | — |
| 8-K |
Current report
Listing notice, Other events
|
Nov 22, 2024 | Nov 22, 2024 |
| 424B3 | Prospectus | Nov 19, 2024 | — |
| 424B3 | Prospectus | Nov 19, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Nov 19, 2024 | Nov 19, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Nov 13, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 5, 2024 | — |
| 8-K |
Current report
Listing notice
|
Nov 1, 2024 | Nov 1, 2024 |
| S-1 | Registration statement | Oct 31, 2024 | — |
| DEF 14A | Proxy statement | Oct 22, 2024 | Oct 22, 2024 |
| EFFECT | Filing | Oct 16, 2024 | — |
| 424B3 | Prospectus | Oct 16, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2024 | — |
| CORRESP | Letter to the SEC | Oct 15, 2024 | — |
| PRE 14A | Preliminary proxy statement | Oct 10, 2024 | Oct 10, 2024 |
| S-1 | Registration statement | Oct 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2024 | Sep 24, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLXN (Nasdaq), SLXNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Ramat Gan, Israel
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2022416
- Former names
- Biomotion Sciences (until Aug 15, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.